Clearside Biomedical, Inc. (CLSDQ) › Total LiabilitiesClearside Biomedical, Inc. (CLSDQ) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $10.40M2016: $13.15M2017: $19.08M2018: $20.50M2019: $15.62M2020: $10.56M2021: $4.93M2022: $40.70M2023: $49.93M2024: $63.98M$63.98M2015Total Liabilities (USD)2024Fiscal YearTotal LiabilitiesChange YoY2024$63.98M+28.1%2023$49.93M+22.7%2022$40.70M+725.8%2021$4.93M-53.3%2020$10.56M-32.4%2019$15.62M-23.8%2018$20.50M+7.5%2017$19.08M+45.0%2016$13.15M+26.5%2015$10.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share